Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.

Nikkilä A; Lohi O; Abrahamsson J; Griskevicius L; Hallböök H; Jónsson ÓG; Lund B; Marquart HV; Overgaard U; Palk K; Pruunsild K; Quist-Paulsen P; Toft N; Vaitkeviciene GE; Wartiovaara-Kautto U; Heyman M; Vettenranta K; Schmiegelow K

doi:10.1038/s41375-025-02789-y

← 뒤로

Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.

0/5 보강

Leukemia 2026 Vol.40(1) p. 215-218

Nikkilä A, Lohi O, Abrahamsson J, Griskevicius L, Hallböök H, Jónsson ÓG, Lund B, Marquart HV, Overgaard U, Palk K, Pruunsild K, Quist-Paulsen P, Toft N, Vaitkeviciene GE, Wartiovaara-Kautto U, Heyman M, Vettenranta K, Schmiegelow K

PMC 전문 ↗ 원문 ↗ DOI ↗ BibTeX ↓ RIS ↓

이 논문을 인용하기

BibTeX ↓ RIS ↓

APA Nikkilä A, Lohi O, et al. (2026). Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.. Leukemia, 40(1), 215-218. https://doi.org/10.1038/s41375-025-02789-y

MLA Nikkilä A, et al.. "Intensive chemotherapy for high-risk acute lymphoblastic leukemia in first remission: results from the NOPHO ALL2008 study.." Leukemia, vol. 40, no. 1, 2026, pp. 215-218.

PMID 41145672

DOI 10.1038/s41375-025-02789-y